# Relapse Prevention Study in Newly Abstinent Smokers

> **NCT00793468** · PHASE2 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Substance Dependence

## Interventions

- **DRUG:** GSK598809
- **DRUG:** Nicotine Replacement Transdermal Patch
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00793468
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-12
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study halted prior to enrollment of patients
- **Last updated:** 2016-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793468, "Relapse Prevention Study in Newly Abstinent Smokers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00793468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*